Physicians' Academy for Cardiovascular Education

Cardio Diabetes Master Class

Debating the optimal management of CV risk and diabetes: Current & Future

Oct. 9, 2011

Cardio Diabetes Master Class


Debating the optimal management of CV risk and diabetes: Current & future
 

View PACE talks and download teaching slides

Warsaw, Poland, October 7-9, 2011

The Cardio Diabetes Master Class is an initiative of the Physicians’ Academy for Cardiovascular Education (PACE) foundation. Our mission is to improve the cardiovascular health of patients by providing a forum for the review, exchange and assimilation of new important data underlying cardiovascular disease, diabetes and accelerate the translation of this information to clinical practice.

The Cardio Diabetes Master Classes are aimed to be dynamic meetings with state of the art lectures, clinical debates, and practical workshops. Participants will be part of an ongoing educational initiative that will provide support to clinicians in their daily clinical management of cardiovascular risk and diabetes.


Scientific rationale educational objectives

  • To explore mechanisms and common pathways underlying the development of cardiovascular disease and diabetes
  • To review and discuss the importance of glucose management and the rationale for early intervention strategies in patients with diabetes
  • To discuss the role of anti-diabetic therapy in a risk-based intervention strategy that targets glucose control and cardiovascular risk factors
  • To define effective blood pressure monitoring strategies to gauge progress towards blood pressure treatment goals, and identify distinctive patterns of blood pressure variability that are associated with individual cardiovascular risk
  • To provide an expert perspective on the expanding role of RAS blockade in multiple organs in the treatment of patients at increased CV risk
  • To provide an expert perspective in the ongoing debate on the role of TZD’s in the treatment of patients with diabetes
  • To discuss current and future strategies for practical management and interventions to prevent cardiovascular events in multirisk patients


View PACE talks with faculty members of the Cardio Diabetes Master Class

Each faculty member provides in 5-10 the key highlights of their presentation

Towards optimal management of CV risk: What are the opportunities?

Prof. MacDonald, UK, discusses the challenges in optimizing CV risk, the pharmacological approach as well as ......

Managing blood pressure: choosing the right strategy to meet BP targets

Prof. Ruilope, Hopital 12 de Octubre, Madrid, Spain discusses recommendations in the management of hypertension and concurrent lifestyle modification.

RAS Blockade in the Real World: From Clinical Trial Data to Challenges in Daily Hypertension Management

Prof. Kjeldsen, University of Oslo, Norway, on the inplementation of clinical trial results in hypertension into daily practice.

Pioglitazone: where do we stand in 2011?

Prof. John Betteridge (UCL, London) gives an update on recent developments with pioglitazone.

Managing blood pressure: The need for individualized treatment considerations to reach targets

Prof. Richard Hobbs (Oxford, UK) emphasized the need for individualized considerations to reach treatment targets.

Achieving optimal glycemic control: What are the current options in management?

Prof. Bernard Charbonell (University of Nantes, France) discussed new options in diabetes management.

View & Download the Key slides presented and developed by faculty members

Pioglitazone: Where do we stand in 2011

Prof. John Betteridge
University College London
London, United Kingdom

Achieving optimal glycemic control: What are the current options in management?

Prof. Bernard Charbonell
University of Nantes,
Nantes, France

Managing blood pressure: choosing the right strategy to meet BP targets

Prof. Luis Ruilope
Hopital 12 de Octubre, Madrid
Spain

RAS blockade in the real world

Prof. Sverre Kjeldsen
University of Oslo, Norway

A new era for CV risk & diabetes management: Treat to earlier, broader and lower targets

Prof. John Deanfield
University College London,
United Kingdom

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: